199 related articles for article (PubMed ID: 26725918)
1. Neurotropin suppresses itch-related behavior in NC/Nga mice with atopic dermatitis-like symptoms.
Kamo A; Tominaga M; Matsuda H; Kina K; Kamata Y; Umehara Y; Ogawa H; Takamori K
J Dermatol Sci; 2016 Mar; 81(3):212-5. PubMed ID: 26725918
[No Abstract] [Full Text] [Related]
2. Oral administration of bepotastine besilate suppressed scratching behavior of atopic dermatitis model NC/Nga mice.
Tanizaki H; Kambe N; Nakamura Y; Tanaka A; Matsuda H; Miyachi Y
Int Arch Allergy Immunol; 2008; 145(4):277-82. PubMed ID: 18004068
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the spontaneous scratching behavior by NC/Nga mice: a possible approach to evaluate antipruritics for subjects with atopic dermatitis.
Takano N; Arai I; Kurachi M
Eur J Pharmacol; 2003 Jun; 471(3):223-8. PubMed ID: 12826242
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of antipruritic effects of several agents on scratching behavior by NC/Nga mice.
Takano N; Arai I; Hashimoto Y; Kurachi M
Eur J Pharmacol; 2004 Jul; 495(2-3):159-65. PubMed ID: 15249165
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of scratching behavior associated with allergic dermatitis in mice by tacrolimus, but not by dexamethasone.
Inagaki N; Shiraishi N; Igeta K; Itoh T; Chikumoto T; Nagao M; Kim JF; Nagai H
Eur J Pharmacol; 2006 Sep; 546(1-3):189-96. PubMed ID: 16914137
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of scratching behavior induced by some chemical mediators in hairless mice.
Takubo M; Ueda Y; Yatsuzuka R; Jiang S; Fujii Y; Kamei C
J Pharmacol Sci; 2006 Apr; 100(4):285-8. PubMed ID: 16565575
[TBL] [Abstract][Full Text] [Related]
7. Topical E6005, a novel phosphodiesterase 4 inhibitor, attenuates spontaneous itch-related responses in mice with chronic atopy-like dermatitis.
Andoh T; Yoshida T; Kuraishi Y
Exp Dermatol; 2014 May; 23(5):359-61. PubMed ID: 24645735
[TBL] [Abstract][Full Text] [Related]
8. Expression of IL-31 gene transcripts in NC/Nga mice with atopic dermatitis.
Takaoka A; Arai I; Sugimoto M; Yamaguchi A; Tanaka M; Nakaike S
Eur J Pharmacol; 2005 Jun; 516(2):180-1. PubMed ID: 15925362
[TBL] [Abstract][Full Text] [Related]
9. Possible Antipruritic Mechanism of Cyclosporine A in Atopic Dermatitis.
Ko KC; Tominaga M; Kamata Y; Umehara Y; Matsuda H; Takahashi N; Kina K; Ogawa M; Ogawa H; Takamori K
Acta Derm Venereol; 2016 Jun; 96(5):624-9. PubMed ID: 26671728
[TBL] [Abstract][Full Text] [Related]
10. Effects of Josamycin on Scratching Behavior in NC/Nga Mice with Atopic Dermatitis-Like Skin Lesions.
Matsui K; Nakamura M; Obana N
Biol Pharm Bull; 2021; 44(6):798-803. PubMed ID: 34078811
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of a chronic pruritus model induced by multiple application of 2,4,6-trinitrochlorobenzene in NC mice.
Yamashita H; Makino T; Mizukami H; Nose M
Eur J Pharmacol; 2007 Jun; 563(1-3):233-9. PubMed ID: 17336291
[TBL] [Abstract][Full Text] [Related]
12. Effects of TS-022, a newly developed prostanoid DP1 receptor agonist, on experimental pruritus, cutaneous barrier disruptions and atopic dermatitis in mice.
Arai I; Takaoka A; Hashimoto Y; Honma Y; Koizumi C; Futaki N; Sugimoto M; Takahashi N; Inoue T; Nakanishi Y; Sakurai T; Tanami T; Yagi M; Ono N; Nakaike S
Eur J Pharmacol; 2007 Feb; 556(1-3):207-14. PubMed ID: 17141215
[TBL] [Abstract][Full Text] [Related]
13. The anti-pruritic efficacy of TS-022, a prostanoid DP1 receptor agonist, is dependent on the endogenous prostaglandin D2 level in the skin of NC/Nga mice.
Sugimoto M; Arai I; Futaki N; Hashimoto Y; Sakurai T; Honma Y; Nakaike S
Eur J Pharmacol; 2007 Jun; 564(1-3):196-203. PubMed ID: 17328887
[TBL] [Abstract][Full Text] [Related]
14. Hypochlorous acid is antipruritic and anti-inflammatory in a mouse model of atopic dermatitis.
Fukuyama T; Martel BC; Linder KE; Ehling S; Ganchingco JR; Bäumer W
Clin Exp Allergy; 2018 Jan; 48(1):78-88. PubMed ID: 29028288
[TBL] [Abstract][Full Text] [Related]
15. Involvement of IL-31 on scratching behavior in NC/Nga mice with atopic-like dermatitis.
Takaoka A; Arai I; Sugimoto M; Honma Y; Futaki N; Nakamura A; Nakaike S
Exp Dermatol; 2006 Mar; 15(3):161-7. PubMed ID: 16480423
[TBL] [Abstract][Full Text] [Related]
16. Barbiturates enhance itch-associated scratching in atopic dermatitis mice: A possible clue to understanding nocturnal pruritus in atopic dermatitis.
Fujii M; Takeuchi K; Umehara Y; Takeuchi M; Nakayama T; Ohgami S; Asano E; Nabe T; Ohya S
Eur J Pharmacol; 2018 Oct; 836():57-66. PubMed ID: 30125561
[TBL] [Abstract][Full Text] [Related]
17. Nalfurafine suppresses pruritogen- and touch-evoked scratching behavior in models of acute and chronic itch in mice.
Akiyama T; Carstens MI; Piecha D; Steppan S; Carstens E
Acta Derm Venereol; 2015 Feb; 95(2):147-50. PubMed ID: 24890341
[TBL] [Abstract][Full Text] [Related]
18. Bee venom ameliorates compound 48/80-induced atopic dermatitis-related symptoms.
Kim KH; Lee WR; An HJ; Kim JY; Chung H; Han SM; Lee ML; Lee KG; Pak SC; Park KK
Int J Clin Exp Pathol; 2013; 6(12):2896-903. PubMed ID: 24294376
[TBL] [Abstract][Full Text] [Related]
19. Involvement of substance P in scratching behaviour in an atopic dermatitis model.
Ohmura T; Hayashi T; Satoh Y; Konomi A; Jung B; Satoh H
Eur J Pharmacol; 2004 May; 491(2-3):191-4. PubMed ID: 15140636
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of scratching behavior in ADJM mice (atopic dermatitis from Japanese mice).
Nakasone T; Sato T; Matsushima Y; Inoue T; Kamei C
Immunopharmacol Immunotoxicol; 2015 Apr; 37(2):202-6. PubMed ID: 25578901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
